Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Increased incidence of multiple sclerosis in systemic sclerosis: A nationwide cohort study.
An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy.
CD4(+)HLA-G(+) regulatory T cells: Molecular signature and pathophysiological relevance.
Identifying clues to molecular etiology of multiple sclerosis in South Indian patients.
White Matter Injury in Ischemic Stroke.
Infectious and noninfectious granulomatosis in patient with multiple sclerosis: diagnostic dilemmas and followup.
Neuromyelitis optica phenotype associated with therapy-responsive acute peripheral neuropathy.
New Perspectives in Pediatric Neurology-Multiple Sclerosis.
Sharing data from MS clinical trials: Opportunities, challenges, and future directions.
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence.
Normal Diffusion-Weighted MRI During the Acute Stage of Central Pontine Myelinolysis.
Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis.
Understanding intellectual enrichment: how cognitive reserve impacts on hippocampal volume in multiple sclerosis.
The interactive web-based program MSmonitor for self-management and multidisciplinary care in multiple sclerosis: utilization and valuation by patients.
Decreased serum IL-27 and IL-35 levels are associated with disease severity in neuromyelitis optica spectrum disorders.
A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR.
[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action].
Expression of a single ICAMâ1 isoform on T cells is sufficient for development of experimental autoimmune encephalomyelitis.
The potential of LINGO-1 as a therapeutic target for essential tremor.
Characteristics of clinical and electrophysiological pattern of Charcot-Marie-Tooth 4C.
Inhibin-a immunoreactivity in nervous system lesions.
Myelinating and demyelinating phenotype of Trembler-J mouse (a model of Charcot-Marie-Tooth human disease) analyzed by atomic force microscopy and confocal microscopy.
Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.
Is there A Genetic Correlation between Multiple Sclerosis and Cerebral Aneurysms?

Pages